Anti-CD3 antibodies
US11319371B2 · kind B2 · utility
0Cited by
0References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2018 |
| Grant date | May 3, 2022 |
| Priority date | — |
| Expiry date | Oct 30, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to novel antibodies that are specific for human CD3, in particular for the CD3ε domain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.